Journal article
Rosuvastatin for the prevention of venous thromboembolism: a pooled analysis of the HOPE-3 and JUPITER randomized controlled trials
Abstract
AIMS: To examine the association between rosuvastatin and VTE risk, and whether effects vary in different subpopulations stratified by key demographic, cardiovascular disease (CVD) risk factors, and other risk factors associated with VTE.
METHODS AND RESULTS: An individual participant data meta-analysis was conducted across two randomized controlled trials in 30 507 participants over a mean follow-up of 3.62 years, individuals had no prior …
Authors
Joseph P; Glynn R; Lonn E; Ramasundarahettige C; Eikelboom J; MacFadyen J; Ridker P; Yusuf S
Journal
Cardiovascular Research, Vol. 118, No. 3, pp. 897–903
Publisher
Oxford University Press (OUP)
Publication Date
February 21, 2022
DOI
10.1093/cvr/cvab078
ISSN
0008-6363